Protecting luxury’s future by creating a positive impact strategy
Leaders must strategize on ways to put sustainability at the core of luxury brand desirability....
YouTube
22 August 2023 • by Jim Pulcrano in Tech for Good
With investors increasingly focusing on ESG topics, you might think that being a Tech for Good company would help attract funding. This is not always the case, says Marc Gitzinger, CEO of...
With investors increasingly focusing on ESG topics, you might think that being a Tech for Good company would help attract funding. This is not always the case, says Marc Gitzinger, CEO of Bioversys, which is developing new medicines for severe life-threatening bacterial infections that are resistant to antibiotics.
In episode five, Gitzinger says the biotech industry still focuses mainly on financial returns and calls on impact investors to pay more attention to the topic of equitable health to ensure access and proper control of good quality drugs throughout the world.
Gitzinger discusses how he defines success, including the importance of generating financial returns for the investors who have believed in the technology and backed the business.
CEO and co-founder of BioVersys
Marc is Chief Executive Officer and co-founder of BioVersys with over 10 years of experience in the biotech industry, having launched a university spin-off in the field of antimicrobial resistance and growing it into a multi-asset clinical stage company.
Adjunct Professor of Entrepreneurship and Management
Jim Pulcrano is an IMD Adjunct Professor of Entrepreneurship and Management. His current projects include teaching in Lausanne, London and Silicon Valley, research on disruption, and various strategy, networking, customer-centricity, and innovation mandates with multinationals in Europe, Asia, and the US. At IMD, He is Director of the Venture Capital Asset Management (VCAM) program and teaches on the Executive MBA (EMBA), Orchestrating Winning Performance (OWP), and full-time MBA programs.
10 February 2023 • by Stéphane J. G. Girod in Videos • 6 min read
Leaders must strategize on ways to put sustainability at the core of luxury brand desirability....
3 January 2023 in Videos • 9 min read • Podcast available
The Wallenberg sphere operates in about 180 countries and its holdings generate a total of $160bn of annual revenue. But Marcus Wallenberg, chairman of the family holding company, explains to Jean-François Manzoni...
20 December 2022 in Videos • 10 min read
Building a social enterprise requires both a big heart and a clear strategic focus, says Khadija Mohamed-Churchill, founder and CEO of Kwanza Tukule. In an in-depth discussion with Jean-Francois Manzoni, she reveals...
16 December 2022 • by Ina Toegel in Videos • 7 min read
The shift to virtual meetings over the past two years has made effective teamworking more challenging, but there are ways of using technology more effectively, according to authors Mike Brent and Nigel...
2 December 2022 • by Knut Haanaes in Videos • 8 min read • Podcast available
The recent COP27 meeting made only limited headway on measures to tackle climate change, but climate action by companies gives more grounds for optimism, and the current challenging economic and geopolitical environment...
2 December 2022 • by Patrick Reinmoeller in Videos • 6 min read
Leaders can harness their attention, motivation, capabilities and capacity to link strategy with culture, and reap benefits for every stakeholder....
1 November 2022 • by Alyson Meister in Videos • 7 min read
Heineken’s Chief People Officer Yolanda Talamo tells Professor Alyson Meister how she is using metrics to address the gender balance, promote cultural diversity and improve wellbeing at the 158-year-old brewer....
21 October 2022 • by Salvatore Cantale in Videos • 5 min read
The next generation of business leaders can play a vital role in speeding up progress on sustainability, according to leadership expert Clarke Murphy. ...
18 October 2022 in Videos • 7 min read
In a CEO Dialogue with IMD President Jean-François Manzoni, Ipsen CEO David Loew discusses his leadership style as he orchestrates the French-born pharma firm’s response to its best-selling drug facing generic...
Explore first person business intelligence from top minds curated for a global executive audience